Ad
related to: eye muscle surgery for strabismus
Search results
Results from the WOW.Com Content Network
Strabismus surgery (also: extraocular muscle surgery, eye muscle surgery, or eye alignment surgery) is surgery on the extraocular muscles to correct strabismus, the misalignment of the eyes. [1] Strabismus surgery is a one-day procedure that is usually performed under general anesthesia most commonly by either a neuro- or pediatric ...
Strabismus surgery attempts to align the eyes by shortening, lengthening, or changing the position of one or more of the extraocular eye muscles. The procedure can typically be performed in about an hour, and requires about six to eight weeks for recovery.
Botulinum toxin therapy of strabismus is a medical technique used sometimes in the management of strabismus, in which botulinum toxin is injected into selected extraocular muscles in order to reduce the misalignment of the eyes. The injection of the toxin to treat strabismus, reported upon in 1981, is considered to be the first ever use of ...
The management of strabismus may include the use of drugs or surgery to correct the strabismus.Agents used include paralytic agents such as botox used on extraocular muscles, [1] topical autonomic nervous system agents to alter the refractive index in the eyes, and agents that act in the central nervous system to correct amblyopia.
MISS is a technique that can be employed for all major types of strabismus surgery like rectus muscle recessions, resections, plications, reoperations, transpositions, oblique muscle recessions, or plications, and adjustable sutures, even in the presence of restricted motility.
With about 1.2 million procedures each year, extraocular muscle surgery is the third-most common eye surgery in the United States. Archived 2016-08-18 at the Wayback Machine. Eye muscle surgery typically corrects strabismus and includes: [27] [28] Loosening or weakening procedures
Daniel Mojon (born July 29, 1963, in Bern, Switzerland) is a Swiss ophthalmologist and ophthalmic surgeon who is considered to be the inventor of minimally invasive strabismus surgery (MISS), a method of surgically correcting squinting that uses only very small incisions of two to three millimeters and is supposed to lead to quicker rehabilitation and wound healing.
Alan Brown Scott (July 13, 1932 – December 16, 2021 [1]) was an American ophthalmologist specializing in eye muscles and their disorders, such as strabismus (eye misalignment). He is best known for his work in developing and manufacturing the drug that became known as Botox, research described as "groundbreaking" by the ASCRS. [2]
Ad
related to: eye muscle surgery for strabismus